Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.

Vaupel DB, Schindler CW, Chefer S, Belcher AM, Ahmet I, Scheidweiler KB, Huestis MA, Stein EA.

Drug Alcohol Depend. 2016 Feb 1;159:181-9. doi: 10.1016/j.drugalcdep.2015.12.008. Epub 2015 Dec 24.

2.

Identifying methamphetamine exposure in children.

Castaneto MS, Barnes AJ, Scheidweiler KB, Schaffer M, Rogers KK, Stewart D, Huestis MA.

Ther Drug Monit. 2013 Dec;35(6):823-30. doi: 10.1097/FTD.0b013e31829685b2.

3.

Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats.

Hadamitzky M, McCunney S, Markou A, Kuczenski R.

Psychopharmacology (Berl). 2012 Oct;223(3):259-69. doi: 10.1007/s00213-012-2713-1. Epub 2012 Apr 20.

4.

Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Kuczenski R, Segal DS, Melega WP, Lacan G, McCunney SJ.

Neuropsychopharmacology. 2009 Oct;34(11):2430-41. doi: 10.1038/npp.2009.73. Epub 2009 Jul 1.

5.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

6.

Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):34-41. doi: 10.1016/j.drugalcdep.2008.10.016. Epub 2008 Dec 5.

7.

Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.

Johnson BA, Wells LT, Roache JD, Wallace CL, Ait-Daoud N, Dawes MA, Liu L, Wang XQ, Javors MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):455-61. Epub 2006 Dec 19.

Supplemental Content

Support Center